Jiangsu Hengrui Medicine Co Ltd Cash Flow Reinvestment Rate
Jiangsu Hengrui Medicine Co Ltd cash flow reinvestment rate. Jiangsu Hengrui Medicine Co Ltd (600276) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥446.90 Million (capex CN¥446.90 Million ) from operating cash flow of CN¥4.81 Billion. See 600276 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Cash flow reinvestment rate of Jiangsu Hengrui Medicine Co Ltd from 1999 to 2024. Historical reinvestment intensity for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. Explore 600276 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Jiangsu Hengrui Medicine Co Ltd Cash Flow Reinvestment Rate by Year (1999–2024)
Jiangsu Hengrui Medicine Co Ltd cash flow reinvestment rate by year from 1999 to 2024. Year-by-year capital reinvestment analysis for Jiangsu Hengrui Medicine Co Ltd. For the full cash flow conversion analysis, see Jiangsu Hengrui Medicine Co Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥2.00 Billion | CN¥7.42 Billion | CN¥1.97 Billion | ▼ -50.5% |
| 2023 | 0.55x | CN¥4.17 Billion | CN¥7.64 Billion | CN¥1.48 Billion | ▼ -71.0% |
| 2022 | 1.88x | CN¥2.38 Billion | CN¥1.27 Billion | CN¥1.99 Billion | ▲ +216.9% |
| 2021 | 0.59x | CN¥2.51 Billion | CN¥4.22 Billion | CN¥1.66 Billion | ▼ -20.4% |
| 2020 | 0.75x | CN¥2.56 Billion | CN¥3.43 Billion | CN¥554.33 Million | ▲ +26.4% |
| 2019 | 0.59x | CN¥2.25 Billion | CN¥3.82 Billion | CN¥561.35 Million | ▼ -47.3% |
| 2018 | 1.12x | CN¥3.11 Billion | CN¥2.77 Billion | CN¥529.11 Million | ▼ -16.7% |
| 2017 | 1.35x | CN¥3.43 Billion | CN¥2.55 Billion | CN¥380.30 Million | ▲ +31.4% |
| 2016 | 1.02x | CN¥2.65 Billion | CN¥2.59 Billion | CN¥1.11 Billion | ▲ +395.4% |
| 2015 | 0.21x | CN¥470.55 Million | CN¥2.28 Billion | CN¥394.09 Million | ▲ +9.0% |
| 2014 | 0.19x | CN¥298.52 Million | CN¥1.57 Billion | CN¥298.52 Million | ▼ -42.9% |
| 2013 | 0.33x | CN¥453.30 Million | CN¥1.36 Billion | CN¥453.30 Million | ▼ -31.8% |
| 2012 | 0.49x | CN¥466.83 Million | CN¥958.37 Million | CN¥466.83 Million | ▼ -52.5% |
| 2011 | 1.02x | CN¥540.27 Million | CN¥527.36 Million | CN¥540.27 Million | ▲ +37.9% |
| 2010 | 0.74x | CN¥286.73 Million | CN¥385.95 Million | CN¥286.73 Million | ▲ +130.3% |
| 2009 | 0.32x | CN¥141.65 Million | CN¥439.12 Million | CN¥141.65 Million | ▼ -65.9% |
| 2008 | 0.95x | CN¥111.21 Million | CN¥117.46 Million | CN¥111.21 Million | ▲ +210.0% |
| 2007 | 0.31x | CN¥66.85 Million | CN¥218.87 Million | CN¥66.85 Million | ▼ -5.8% |
| 2006 | 0.32x | CN¥86.29 Million | CN¥266.18 Million | CN¥86.29 Million | ▲ +17.1% |
| 2005 | 0.28x | CN¥63.07 Million | CN¥227.88 Million | CN¥63.07 Million | ▼ -26.7% |
| 2004 | 0.38x | CN¥79.11 Million | CN¥209.41 Million | CN¥79.11 Million | ▼ -76.1% |
| 2003 | 1.58x | CN¥216.62 Million | CN¥136.82 Million | CN¥216.62 Million | ▼ -35.8% |
| 2002 | 2.47x | CN¥122.90 Million | CN¥49.84 Million | CN¥122.90 Million | ▼ -89.7% |
| 2001 | 23.99x | CN¥275.58 Million | CN¥11.49 Million | CN¥275.58 Million | ▲ +478.2% |
| 2000 | 4.15x | CN¥81.34 Million | CN¥19.61 Million | CN¥81.34 Million | ▲ +591.8% |
| 1999 | 0.60x | CN¥20.32 Million | CN¥33.89 Million | CN¥20.32 Million | — |